Valuation Is a Financial Conversation: When a sophisticated buyer evaluates an OB/GYN practice, they are not making an intuitive judgment about its quality; they are constructing a financial model. That model is anchored by a discrete set of metrics that determine how much EBITDA the practice generates on a normalized, sustainable basis, and what multiple the market will pay for that earnings stream. Understanding these metrics is the first step toward understanding your practice’s value, and toward taking actions that can meaningfully increase it before going to market.
1. Normalized EBITDA
Normalized EBITDA, earnings before interest, taxes, depreciation, and amortization, adjusted for non-recurring items and owner-specific expenses, is the single most important driver of practice value. Buyers will add back legitimate one-time expenses (such as a one-time legal settlement or a non-recurring capital expenditure), normalize owner compensation to fair market value, and adjust for personal expenses run through the practice. The resulting normalized EBITDA is the denominator in the multiple equation: if your practice generates $3 million in normalized EBITDA and the applicable market multiple is 8x, your practice is worth approximately $24 million. A single turn of multiple or $250,000 of additional normalized EBITDA represents $2 million in enterprise value.
2. Revenue Per Provider
Revenue per physician (or per full-time equivalent provider) is a key operational benchmark that buyers use to assess productivity and identify upside potential. A practice whose revenue per provider lags its peer group may be underperforming in scheduling efficiency, billing capture, or coding optimization, which represent identifiable opportunities for improvement. Conversely, a practice with above-average revenue per provider demonstrates strong operational management and is likely to attract premium valuation attention.
3. Payer Mix
As discussed in earlier articles, payer mix is a critical quality-of-earnings consideration. Buyers consistently apply a premium to practices with a high proportion of commercial insurance revenue and apply discounts to practices with heavy Medicaid or self-pay exposure. Improving your payer mix through targeted marketing, managed care contracting, and selective patient acquisition strategies can meaningfully increase your practice’s attractiveness to buyers and the multiple they are willing to pay.
4. Working Capital and Revenue Cycle Efficiency
Buyers will examine accounts receivable aging, claims denial rates, and days in A/R as indicators of revenue cycle health. The Medical Group Management Association (MGMA) has found that 86% of claim denials are avoidable, yet nearly 24% of denied claims are never successfully reworked. A practice with a high denial rate, aged receivables, or slow collection cycles signals management risk to buyers and can trigger a working capital adjustment that reduces net proceeds at closing. Clean, efficient revenue cycle operations are both a valuation driver and a due diligence risk mitigation strategy.
5. Physician Retention and Contract Structure
Buyer underwriting is fundamentally about earnings durability. A practice in which key physicians operate without long-term agreements, are nearing retirement age, or have expressed an intention to reduce their clinical activity, poses a revenue risk that buyers will price into their offers. Practices where younger physicians are under long-term agreements, where leadership depth extends beyond the founding generation, and where clinical schedules are well-documented and sustainable consistently achieve 1X to 2X higher multiples than comparable practices with physician continuity risks. Investing in physician retention and succession planning before going to market is one of the highest-return value creation activities available to practice owners.